260 related articles for article (PubMed ID: 17323312)
1. Optimal design of clinical trials comparing several treatments with a control.
Marschner IC
Pharm Stat; 2007; 6(1):23-33. PubMed ID: 17323312
[TBL] [Abstract][Full Text] [Related]
2. Power and sample size when multiple endpoints are considered.
Senn S; Bretz F
Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
[TBL] [Abstract][Full Text] [Related]
3. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
4. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
Pigeot I; Schäfer J; Röhmel J; Hauschke D
Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
[TBL] [Abstract][Full Text] [Related]
5. Noninferiority testing beyond simple two-sample comparison.
Tsong Y; Chen WJ
J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
[TBL] [Abstract][Full Text] [Related]
6. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
7. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
Lai TL; Shih MC; Zhu G
Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
[TBL] [Abstract][Full Text] [Related]
8. Implementing a decision-theoretic design in clinical trials: why and how?
Palmer CR; Shahumyan H
Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
[TBL] [Abstract][Full Text] [Related]
9. Multiplicity and flexibility in clinical trials.
Brannath W; Koenig F; Bauer P
Pharm Stat; 2007; 6(3):205-16. PubMed ID: 17674349
[TBL] [Abstract][Full Text] [Related]
10. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
Dilba G; Bretz F; Hothorn LA; Guiard V
Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
[TBL] [Abstract][Full Text] [Related]
11. A generalized concept of power helped to choose optimal endpoints in clinical trials.
Borm GF; van der Wilt GJ; Kremer JA; Zielhuis GA
J Clin Epidemiol; 2007 Apr; 60(4):375-81. PubMed ID: 17346612
[TBL] [Abstract][Full Text] [Related]
12. Sample size for two-stage studies with maintenance therapy.
Feng W; Wahed AS
Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
[TBL] [Abstract][Full Text] [Related]
13. Testing non-inferiority and superiority for two endpoints for several treatments with a control.
Lawrence J
Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636
[TBL] [Abstract][Full Text] [Related]
14. Test for the consistency of noninferiority from multiple clinical trials.
Yan X; Wang MC; Su X
J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
[TBL] [Abstract][Full Text] [Related]
15. Sample size formulae for trials comparing group and individual treatments in a multilevel model.
Moerbeek M; Wong WK
Stat Med; 2008 Jul; 27(15):2850-64. PubMed ID: 17960589
[TBL] [Abstract][Full Text] [Related]
16. Multiple comparisons to both a negative and a positive control.
Hasler M
Pharm Stat; 2012; 11(1):74-81. PubMed ID: 22232049
[TBL] [Abstract][Full Text] [Related]
17. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
18. Mixed noninferiority margin and statistical tests in active controlled trials.
Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
[TBL] [Abstract][Full Text] [Related]
19. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
Tsong Y; Shen M
J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
[TBL] [Abstract][Full Text] [Related]
20. Optimal conditional error functions for the control of conditional power.
Brannath W; Bauer P
Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
